A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive AdultsJames E. Moon, April Sikaffy, Cynthia Lee et al.|The Journal of Infectious Diseases|2020Cited by 46
Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trialKayvon Modjarrad, Emmanuel Feroldi, Meshell Morrison et al.|The Lancet Infectious Diseases|2024Cited by 8